Franchise opportunities compared
Medicap Pharmacies vs NexGenEsis Healthcare
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Before you compare
- Both sets of figures come from 2025 FDDs.
- Medicap Pharmacies discloses more than one business format, so the investment range spans formats; the full report breaks them out.
- Only NexGenEsis Healthcare has reviewed Item 19 figures here.
| Disclosure | MPMedicap Pharmacies | NHNexGenEsis Healthcare |
|---|---|---|
| Financial commitment | ||
| Estimated initial investment (Item 7) | $130,000 – $546,653 2025 FDD · Item 7 | Not available No reviewed Item 7 total |
| Standard initial franchise fee (Item 5) | $0.00 2025 FDD · Item 5 · PDF p. 18 · printed p. 10 | Not available No single standard fee identified |
| Royalty (Item 6) | $3.00 Continuing license fee — rate alternative 2025 FDD · Item 6 · PDF p. 18 · printed p. 10 | $7.00 Royalty rate 2025 FDD · Item 6 · PDF p. 19 |
| Brand / advertising fund (Item 6) | $310 PMA digital marketing — low monthly 2025 FDD · Item 6 · PDF p. 20 · printed p. 12 | $1.00 Brand Fund annual increase cap 2025 FDD · Item 6 · PDF p. 19 |
| System scale & health | ||
| Total outlets (Item 20) | Not available No reviewed outlet counts | Not available No reviewed outlet counts |
| Net outlet change (Item 20) | Not available Only one year reported | Not available Only one year reported |
| Outlet exits (Item 20) | Not available No complete exit records for a year | Not available No complete exit records for a year |
| Franchising since (Item 1) | Not available Not in reviewed records | Not available Not in reviewed records |
| Franchisor founded (Item 1) | Not available Not in reviewed records | Not available Not in reviewed records |
| Performance (Item 19) | ||
| Financial performance (Item 19), by location group | Not disclosed — no Item 19 financial performance representation | Franchised (1 locations) — EBITDA and costs and other measures and revenue and profit -$64,254.00 other Adjusted EBITDA · 2025 FDD · Item 19 · PDF p. 63 Locations counted not stated in the reviewed record 3 locations other Affiliate Reporting Group reporting locations · 2025 FDD · Item 19 · PDF p. 61 |
Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.